Andrew John Matthew Clark
Vorsitzender bei vasopharm GmbH
Vermögen: 235 507 $ am 31.05.2024
Profil
Andrew John Matthew Clark was the founder of Reabourne Ltd., which was founded in 1995 where he held the title of Portfolio Manager from 1995 to 2003.
He is currently the Chairman-Supervisory Board at vasopharm GmbH.
Dr. Clark's former positions include Director at Liminal BioSciences, Inc., Senior Independent Non-Executive Director at Lifeline Scientific, Inc., and Director at Hologic Ltd.
Dr. Clark received a doctorate degree from the University of St. Andrews.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 01.05.2023 | 3 066 502 ( 1,08% ) | 235 507 $ | 31.05.2024 |
Aktive Positionen von Andrew John Matthew Clark
| Unternehmen | Position | Beginn |
|---|---|---|
vasopharm GmbH
 vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Vorsitzender | - |
Ehemalige bekannte Positionen von Andrew John Matthew Clark
| Unternehmen | Position | Ende |
|---|---|---|
| Reabourne Ltd. | Gründer | 01.01.2003 |
| LIMINAL BIOSCIENCES INC. | Direktor/Vorstandsmitglied | - |
| LIFELINE SCIENTIFIC, INC | Direktor/Vorstandsmitglied | - |
Hologic Ltd.
 Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Direktor/Vorstandsmitglied | - |
Ausbildung von Andrew John Matthew Clark
| University of St. Andrews | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| LIMINAL BIOSCIENCES INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
Lifeline Scientific, Inc.
 Lifeline Scientific, Inc. Medical SpecialtiesHealth Technology Lifeline Scientific, Inc. engages in the development and marketing of advanced medical products and services. It focuses on tissue testing technologies. It also intends to provide more and better quality organs, tissues and cells, in support of transplant professionals worldwide, and the life-saving services. The company was founded by David Kravitz on October 1, 1998 and is headquartered in Itasca, IL. | Health Technology |
Hologic Ltd.
Hologic Ltd. Medical SpecialtiesHealth Technology Hologic Ltd. manufactures life sciences products and services with two divisions, Molecular Diagnostics and Research Products & Services. The firm has laboratories, manufacturing and operations in the USA, UK and France. It provides test kits, reagents and services to two synergistic markets. It focuses on these niche opportunities with products, patents, expertise and acquisitions. The company was founded in 1992 and is headquartered in Wythenshawe, the United Kingdom. | Health Technology |
vasopharm GmbH
vasopharm GmbH Pharmaceuticals: MajorHealth Technology vasopharm GmbH operates as a pharmaceutical company. It discovers and develops novel therapeutics for the treatment of cerebro and cardiovascular diseases and their consequences. The firm focuses on therapeutics influencing the bioavailability of nitric oxide. The company was founded by Harald Schmidt and Ulrich Walter in July 1998 and is headquartered in Wuerzburg, Germany. | Health Technology |
| Reabourne Ltd. |
